| 2013-06-03 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 167,294 0.0103% | $48.18 | $8.06M | +7.05% | |
| 2013-05-30 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 287,042 0.0175% | $47.23 | $13.56M | +8.35% | |
| 2013-04-30 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 709,774 0.0431% | $39.62 | $28.12M | +26.01% | |
| 2013-04-29 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 264,776 0.0161% | $39.93 | $10.57M | +25.36% | |
| 2013-02-08 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 449,410 0.0273% | $36.79 | $16.53M | +24.04% | |
| 2012-12-11 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 188,708 0.0115% | $33.00 | $6.23M | +33.71% | |
| 2011-05-18 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 1,460 <0.0001% | $28.70 | $41,904 | +14.66% | |
| 2011-05-16 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 141,610 0.0083% | $28.90 | $4.09M | +14.83% | |
| 2010-03-15 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 95,126 0.0055% | $25.94 | $2.47M | +3.5% | |
| 2009-12-23 | Sale | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 25,188 – | $0 | $0 | +2.75% | |
| 2009-04-30 | Bristol-Myers Squibb Company BMY | EVP, CSO & President R&D | 30,000 0.0015% | $19.18 | $575,400 | +21.52% |